Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle (Q51808314)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 February 2009

Language	Label	Description	Also known as
English	Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle	scientific article published on 23 February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Yan Yue

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Wei Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Linkun Hu

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Zhenggang Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

Sidong Xiong

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

language of work or name

0 references

publication date

23 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

386

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

438-447

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

T-cell cytokines affect mucosal immunoglobulin A transport

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Evolution, development, mechanism and function of IgA in the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Fusion expression of bovine lactoferricin in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Tuning inflammation and immunity by chemokine sequestration: decoys and more

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Sublingual vaccination with influenza virus protects mice against lethal viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Polymeric nanoparticles for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.029

7 January 2021

Identifiers

10.1016/J.VIROL.2009.01.029

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19233446

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51808314&oldid=2283202627"